OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
Virginie Baylot(Inserm), Palma Rocchi(Centre National de la Recherche Scientifique)
Cited by 100
Related Papers
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
|Oncotarget|2017|11